Comment on: "Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen"

Eye (Lond). 2024 Sep;38(13):2661. doi: 10.1038/s41433-024-03063-8. Epub 2024 Apr 8.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Angiogenesis Inhibitors* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Choroidal Neovascularization / drug therapy
  • Disease Progression*
  • Humans
  • Intravitreal Injections
  • Macular Degeneration* / drug therapy
  • Ranibizumab / administration & dosage
  • Ranibizumab / therapeutic use
  • Wet Macular Degeneration / drug therapy

Substances

  • Angiogenesis Inhibitors
  • Ranibizumab
  • Antibodies, Monoclonal, Humanized